LGALS9 and cancer: Among the 16 known galectins, Gal-1 and Gal-3 have been studied most.247–249 In recent years, Gal-9 and Gal-8 have also gained attention, since inhibitors of these galectins have the potential for the treatment of cancer and fibrosis.